Drugs Made In America Acquisition II Corp. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Do Catherine | — | Other | 100,000 | — | — | 100,000 | Sep 26, 2025 |
| Shulgan Myron W. | — | Other | 100,000 | — | — | 100,000 | Sep 26, 2025 |
| Worman Glenn C. | CFO | Other | 100,000 | — | — | 100,000 | Sep 26, 2025 |
| Stockwell Lynn | CEO and Exe. Chair of Board | Other | 400,000 | — | — | 14,675,000 | Sep 26, 2025 |
| Drugs Made In America Acquisition II LLC | — | Sale | 7,966,667 | — | — | 6,708,333 | Sep 26, 2025 |
| Prasad Sridhar G. | — | Other | 100,000 | — | — | 100,000 | Sep 26, 2025 |